Novavax, Inc. short interest in 2019
In 2019, Novavax, Inc.'s disclosed short interest ran from 16.00% of shares outstanding on 15 Jan 2019 to 20.41% on 31 Dec 2019, a change of +4.41 percentage points. The year's high was 21.78% on 15 Apr 2019 and its low 16.00% on 15 Jan 2019, averaging 19.52% across 19 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.18 days on 31 Jul 2019. Full history: Novavax, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2019 in figures
- Start of year
- 16.00% (15 Jan 2019)
- End of year
- 20.41% (31 Dec 2019)
- Change
- +4.41 pp
- High
- 21.78% (15 Apr 2019)
- Low
- 16.00% (15 Jan 2019)
- Average
- 19.52%
- Highest days to cover
- 11.18 (31 Jul 2019)
- SEC filings marked
- 8
Every report in 2019
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2019 | 16.00% | 5.38 | |
| 31 Jan 2019 | 16.66% | 7.72 | |
| 15 Feb 2019 | 18.94% | 9.84 | |
| 28 Feb 2019 | 20.68% | 3.91 | |
| 15 Mar 2019 | 21.41% | 3.00 | |
| 29 Mar 2019 | 20.84% | 4.17 | 10-K filed, results (8-K) |
| 15 Apr 2019 | 21.78% | 7.49 | |
| 30 Apr 2019 | 18.76% | 8.31 | |
| 31 Jul 2019 | 21.73% | 11.18 | 10-Q filed, results (8-K) |
| 15 Aug 2019 | 21.34% | 3.84 | 10-Q filed, results (8-K) |
| 30 Aug 2019 | 20.13% | 3.43 | |
| 13 Sep 2019 | 20.46% | 7.12 | |
| 30 Sep 2019 | 20.54% | 6.24 | |
| 15 Oct 2019 | 19.00% | 9.73 | |
| 31 Oct 2019 | 17.63% | 9.22 | |
| 15 Nov 2019 | 17.66% | 7.11 | 10-Q filed, results (8-K) |
| 29 Nov 2019 | 18.23% | 4.43 | |
| 13 Dec 2019 | 18.66% | 3.34 | |
| 31 Dec 2019 | 20.41% | 6.47 |
See also: Novavax, Inc.'s full history · most shorted US stocks of 2019 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.